[New indications for gamma globulins]. Fontán G, García MC, Pascual-Salcedo D, López Trascasa M, Alvarez Doforno R, Ferreira A. An Esp Pediatr. 1992 Jun;36:135-8. PMID: 1379010
The clinical use of intravenous immunoglobulin in pediatrics. Wahn V. Indian J Pediatr. 1987 Sep-Oct;54(5):641-53. doi: 10.1007/BF02751271. PMID: 3428982
[Intravenous immunoglobulins. Basic principles, selection criteria and indications for preventive and therapeutic administration]. Böger RH, Bode-Böger SM, Frölich JC. Med Klin (Munich). 1995 Sep 15;90(9):520-6. PMID: 7476730
Efficacy of a new intravenous immunoglobulin preparation in primary immunodeficient patients. Ochs HD, Lee ML, Fischer SH, Kingdon HS, Wedgwood RJ. Clin Ther. 1987;9(5):512-22. PMID: 3117369
IVIg for GBS: potential problems in the alphabet soup. Bleck TP. Neurology. 1993 May;43(5):857-8. doi: 10.1212/wnl.43.5.857. PMID: 8492935
Immunoglobulin therapy: methods of delivery. Ballow M. J Allergy Clin Immunol. 2008 Nov;122(5):1038-9. doi: 10.1016/j.jaci.2008.08.012. Epub 2008 Sep 19. PMID: 18804269
[Immunoglobulins and immune deficiency: methods of administration]. Suarez F. Rev Med Interne. 2005 Oct;26:25-8. PMID: 16475260
The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipids. Vuist WM, Van Schaik IN, Van Lint M, Brand A. J Clin Immunol. 1997 Jul;17(4):301-10. doi: 10.1023/a:1027326731945. PMID: 9258769
Surveillance of adverse reactions in patients self-infusing intravenous immunoglobulin at home. Brennan VM, Cochrane S, Fletcher C, Hendy D, Powell P. J Clin Immunol. 1995 Mar;15(2):116-9. doi: 10.1007/BF01541739. PMID: 7559908
Common variable immunodeficiency: clinical aspects and recent progress in identifying the immunological defect(s). Eibl MM, Wolf HM. Folia Microbiol (Praha). 1995;40(4):360-6. doi: 10.1007/BF02814744. PMID: 8763150
Efficacy of intravenous immunoglobulin in chronic idiopathic pericarditis: report of four cases. Peterlana D, Puccetti A, Simeoni S, Tinazzi E, Corrocher R, Lunardi C. Clin Rheumatol. 2005 Feb;24(1):18-21. doi: 10.1007/s10067-004-0959-7. Epub 2004 Jul 14. PMID: 15674654
Tolerability of a new 10% liquid immunoglobulin for intravenous use, Privigen, at different infusion rates. Sleasman JW, Duff CM, Dunaway T, Rojavin MA, Stein MR. J Clin Immunol. 2010 May;30(3):442-8. doi: 10.1007/s10875-010-9373-x. Epub 2010 Mar 10. PMID: 20217199
Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort "Visages". Bienvenu B, Cozon G, Hoarau C, Pasquet M, Cherin P, Clerson P, Hachulla E, Crave JC, Delain JC, Jaussaud R. Orphanet J Rare Dis. 2016 Jun 22;11(1):83. doi: 10.1186/s13023-016-0452-9. PMID: 27334100
Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials . Frenzel W, Wietek S, Svae TE, Debes A, Svorc D. Int J Clin Pharmacol Ther. 2016 Nov;54(11):847-855. doi: 10.5414/CP202782. PMID: 27719744
Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy. Hill JA, Krantz EM, Hay KA, Dasgupta S, Stevens-Ayers T, Bender Ignacio RA, Bar M, Maalouf J, Cherian S, Chen X, Pepper G, Riddell SR, Maloney DG, Boeckh MJ, Turtle CJ. Blood Adv. 2019 Nov 26;3(22):3590-3601. doi: 10.1182/bloodadvances.2019000717. PMID: 31743392
The use of intravenous immunoglobulins in symptomatic HIV infection. Results of a randomized study. Jablonowski H, Sander O, Willers R, Adams O, Bartmann P, Wahn V. Clin Investig. 1994 Feb;72(3):220-4. doi: 10.1007/BF00189318. PMID: 7912123
Suppression of allo-human leucocyte antigen (HLA) antibodies secreted by B memory cells in vitro: intravenous immunoglobulin (IVIg) versus a monoclonal anti-HLA-E IgG that mimics HLA-I reactivities of IVIg. Zhu D, Ravindranath MH, Terasaki PI, Miyazaki T, Pham T, Jucaud V. Clin Exp Immunol. 2014 Aug;177(2):464-77. doi: 10.1111/cei.12307. PMID: 24611451
Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production. Heidt S, Roelen DL, Eijsink C, Eikmans M, Claas FH, Mulder A. Clin Exp Immunol. 2009 Oct;158(1):99-105. doi: 10.1111/j.1365-2249.2009.03996.x. PMID: 19737236
